The bill requires the Secretary of Veterans Affairs and the Secretary of Defense to furnish stellate ganglion block (SGB) to veterans and service members who (1) are enrolled in VA or TRICARE, (2) have been diagnosed with post-traumatic stress disorder (PTSD), and (3) elect to receive SGB after being informed of risks and benefits by a qualified provider. It adds new statutory sections to 38 U.S.C. (section 1720M) and 10 U.S.C. (section 1074p) to create that entitlement and permits the Secretaries to provide care through Department facilities or authorized network providers.
The bill sets an effective date 180 days after enactment and requires the VA/DoD joint clinical practice guideline for PTSD to be updated within 180 days to reflect SGB availability and list clinical indicators and contraindications.
This matters because the legislation converts an emerging, procedure-based therapy into a covered option across the federal military and veterans health systems. That change forces regulators and clinical operations teams to decide how to credential providers, deliver and bill for the procedure, measure outcomes, and manage demand — all while scientific consensus about SGB’s efficacy for PTSD remains limited and evolving.
Compliance officers, chief medical officers, and budget analysts should treat this as an operational mandate with clinical and fiscal consequences rather than a narrow clinical update.
At a Glance
What It Does
The bill adds statutory entitlements requiring VA and DoD to furnish stellate ganglion block to eligible enrollees diagnosed with PTSD who opt for the therapy after informed consent. It authorizes delivery through VA/DoD facilities or participating providers and mandates a joint VA/DoD guideline update within 180 days to include indicators and contraindications.
Who It Affects
Directly affected are veterans enrolled under 38 U.S.C. §1705, active-duty and reserve service members enrolled in TRICARE, VA and DoD medical facilities, and private clinicians participating in VA community care or TRICARE networks. Indirectly affected are credentialing offices, medical supply chains, and TRICARE payment administrators.
Why It Matters
The bill creates a programmatic obligation to provide a specific interventional procedure across large federal health systems, setting a precedent for adding emerging therapies by statute rather than through internal clinical review. That approach will drive rapid operational changes — training, credentialing, procurement, and utilization oversight — and may shift treatment patterns for PTSD within the military-veteran continuum.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill instructs the VA and the Department of Defense to make stellate ganglion block available to enrolled veterans and TRICARE-enrolled service members diagnosed with PTSD who request it after receiving informed counseling about risks and benefits. Rather than simply enabling pilot programs or issuing guidance, the bill creates statutory language that requires furnishing the procedure, which signals a legal entitlement for eligible patients once the effective date arrives.
Delivery can occur inside Department-run medical facilities or via authorized external providers: for veterans, through VA facilities or providers covered by the VA’s community care authorities; for service members, through military medical facilities or TRICARE-participating clinicians. The statute does not prescribe detailed clinical protocols, reimbursement rates, or whether the procedure must be preceded or followed by other PTSD treatments, leaving those operational choices to the agencies and their updated guideline.To steer clinical practice, the bill forces an update to the VA/DoD joint Clinical Practice Guideline for PTSD within 180 days.
That update must acknowledge SGB as an available option and list clinical indicators and contraindications; the Secretaries must then notify congressional defense committees and veterans’ affairs committees. The requirement for a guideline update and notification is procedural but meaningful: it establishes an expectation that the Departments will define candidate selection criteria and safety checks within a compressed timetable.Practically, implementing this bill will require hospitals and clinics to revise credentialing rules to identify who counts as a “qualified health care provider,” adopt standardized informed-consent language, stock supplies and imaging support for an interventional procedure, and build documentation and outcomes-tracking into electronic health records.
It also raises questions for TRICARE claims processing and for whether the Departments will request additional appropriations or absorb costs in existing budgets.
The Five Things You Need to Know
The bill adds new statutory entitlements at 38 U.S.C. §1720M (veterans) and 10 U.S.C. §1074p (service members) requiring VA and DoD to furnish stellate ganglion block to eligible enrollees diagnosed with PTSD.
Eligibility requires three elements: enrollment in VA patient enrollment under 38 U.S.C. §1705 or TRICARE coverage, a documented PTSD diagnosis, and an informed election to receive SGB from a qualified provider.
The Secretaries may furnish SGB through Department medical facilities or through community/participating providers (VA community care authorities and TRICARE network providers), rather than limiting care to intra‑system clinics.
The bill requires the VA and DoD to update the joint VA/DoD Clinical Practice Guideline for PTSD within 180 days to reflect SGB availability and to list clinical indicators and contraindications, and to notify specified congressional committees of that update.
The statute’s effective date for the new sections is 180 days after enactment, creating a short window for agencies to prepare credentialing, supply, training, billing, and data-collection systems.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
This single-line section names the measure the "Treatment and Relief through Emerging and Accessible Therapy for PTSD Act" or the "TREAT PTSD Act." It has no substantive effect but frames legislative intent to treat SGB as an accessible therapy option within federal systems.
VA obligation to furnish SGB to eligible veterans
Subsection (a) amends chapter 17 of title 38 by adding §1720M, which requires the Secretary of Veterans Affairs to furnish SGB to veterans enrolled under §1705 who have a PTSD diagnosis and who elect the therapy after informed counseling. The provision explicitly authorizes provision through VA facilities or through providers designated under 38 U.S.C. §1703(c) (community providers), which means the VA can use its community care authorities to meet demand. Operationally, this creates a statutory entitlement for enrolled veterans that will require VA to define provider qualifications, consent procedures, and documentation standards.
DoD/TRICARE obligation to furnish SGB to covered members
This subsection inserts a new §1074p into chapter 55 of title 10 requiring the Secretary of Defense to furnish SGB to active-duty service members and reservists enrolled in TRICARE who have PTSD and opt for the procedure after being informed of risks and benefits. The DoD may deliver care through military treatment facilities or TRICARE-participating providers. This mirrors the VA’s statutory framework but interacts with TRICARE authorization, network participation rules, and DoD credentialing processes.
Mandatory update of the VA/DoD PTSD Clinical Practice Guideline
The bill requires the Secretaries to update the jointly published VA/DoD Clinical Practice Guideline for PTSD within 180 days to include SGB as a therapy option and to list clinical indicators and contraindications. It also requires formal notification to the congressional defense committees and the veterans’ affairs committees once the guideline is updated. That obligation forces the Departments to specify candidate selection criteria, safety checks, and likely places SGB fits within multimodal PTSD care within a short timeframe.
Effective date
The statutory additions take effect 180 days after enactment. That single date creates a clear compliance trigger for both Departments and compresses planning and implementation activities — credentialing, supply procurement, staff training, and claims-rule updates — into a finite preparatory window.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Veterans enrolled in the VA system diagnosed with PTSD: they receive a statutory entitlement to request and obtain SGB through VA facilities or authorized community providers, expanding their treatment options.
- Active-duty and reserve service members covered by TRICARE with PTSD: the bill makes SGB a covered option within the military healthcare entitlement, potentially improving access for those who seek interventional treatments.
- Pain management and interventional clinicians (anesthesiologists, pain specialists, interventional radiologists): they may see increased referrals and clearer billing pathways when VA and DoD adopt SGB as a covered therapy and define qualification standards.
Who Bears the Cost
- Department of Veterans Affairs and Department of Defense health systems: they must absorb or budget for increased demand, provider training, equipment and supply procurement, credentialing workload, and outcomes-tracking without any appropriation language in the bill.
- TRICARE program and federal health administrators: claims processing, network participation rules, and payment policies will need updates, potentially increasing administrative costs for DoD medical and civilian contractors.
- Clinical operations and credentialing offices: these units must define who qualifies as a ‘qualified health care provider,’ create consent forms and documentation standards, and monitor safety and utilization — work that consumes staff time and administrative resources.
Key Issues
The Core Tension
The central dilemma is between expanding patient access to an emerging, demand-driven therapy and the government’s duty to provide care that is evidence-based and fiscally sustainable: the bill privileges patient choice and access by statute, but it pushes VA and DoD to implement a resource-intensive procedure before consensus on long-term efficacy, optimal patient selection, and system-level costs is fully established.
The most immediate implementation question is evidentiary: SGB remains an emerging therapy for PTSD with a mixed and relatively small evidence base compared with established psychotherapies and pharmacotherapies. The bill does not require the Departments to condition coverage on specific evidence thresholds, outcomes tracking, or participation in registries, so agencies may confront pressure to provide access before robust effectiveness and safety data accumulate.
Another practical tension is the resource and operational burden. The statute creates an entitlement without accompanying funding or detailed implementation standards.
Agencies will need to decide whether to expand in‑house capacity or rely on community providers; either choice triggers credentialing, training, supply, imaging, anesthesia support, and liability-management workstreams. The 180-day window for guideline updates and the 180-day effective date compress preparation time and increases the risk that agencies will approve wide access before safety and utilization controls are in place.
Finally, the bill leaves ambiguous several implementation details that matter clinically and legally: it does not define "qualified health care provider" or require specific consent language, nor does it require coordination with existing PTSD treatment pathways (for example, whether SGB replaces, supplements, or requires concurrent psychotherapy). Those gaps raise questions about standard-of-care boundaries, billing rules, medical board oversight, and potential variability in access across regions and facilities.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.